Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
20
|
pubmed:dateCreated |
1996-5-30
|
pubmed:commentsCorrections | |
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
AIM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
May
|
pubmed:issn |
0028-4793
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:day |
16
|
pubmed:volume |
334
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
1333; author reply 1334-5
|
pubmed:dateRevised |
2004-11-17
|
pubmed:meshHeading |
pubmed-meshheading:8609956-Anticholesteremic Agents,
pubmed-meshheading:8609956-Coronary Disease,
pubmed-meshheading:8609956-Drug Costs,
pubmed-meshheading:8609956-Female,
pubmed-meshheading:8609956-Humans,
pubmed-meshheading:8609956-Hypercholesterolemia,
pubmed-meshheading:8609956-Male,
pubmed-meshheading:8609956-Pravastatin
|
pubmed:year |
1996
|
pubmed:articleTitle |
Prevention of coronary heart disease with pravastatin.
|
pubmed:publicationType |
Letter,
Comment
|